OTHER
Therapeutics
Blood pressure–lowering did not improve short-term mortality or dependency in acute stroke and hypertension
| The first 150 words of the full text of this article appear below. |
randomised placebo controlled trial (Controlling Hypertension and Hypotension Immediately Post Stroke [CHHIPS] study).
concealed.*
blinded (patients and researchers).*
6 centres in England, UK.
179 patients >18 years of age with a fixed neurological deficit lasting >60 min, clinical diagnosis of suspected stroke, and symptom onset within 36 hours (depressor group) and hypertension (mean systolic blood pressure [BP] level >160 mm Hg). Exclusion criteria included current antihypertensive therapy in non-dysphagic patients, contraindications to trial therapy, and significant comorbidity or life expectancy <6 months. The pressor group (symptom onset <12 h and hypotension) had only 1 patient, was discontinued, and is not reported here.
lisinopril, 5–15 mg daily (n = 58), labetalol, 50–150 mg on day 1 then 100–300 mg daily (n = 58), or placebo (n = 63) for 2 weeks, with the dose dependent on achieving target systolic BP. Treatment was given orally in non-dysphagic patients and sublingually (lisinopril)
Northwestern University Feinberg School of Medicine, Chicago, Illinois, US
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
